Global Prostate Cancer Therapeutics Market to Witness High Demand Due to Increasing Cases of Prostate Cancer

Prostate Cancer Therapeutics Market is forecasted to grow at 7.70% for 2020 to 2027 to an estimated value of USD 18.71 billion by 2027 with factors such as high cost of the treatment and risk associated with the side effects of treatment hampering the market growth.

Prostate cancer therapeutics market has shown a significant adoption rate and preferences from the North America region with countries such as U.S. and Canada. Increasing cases of prostate cancer in the region is expected to enhance the market growth.

Prostate Cancer Therapeutics Market Scenario

According to Data Bridge Market Research the prostate cancer therapeutics market in developing regions is witnessing a growth in terms of its adoption rate, due to rising R&D investment in the oncology therapeutic areas, development in proteomics & genomics, increasing old male population and rising pharmaceutical expenditure.  

Now the question is which are the regions that prostate cancer therapeutics market players should target? Data Bridge Market Research has forecasted market leaders to target North America developing regions to help them in attaining better volume of revenue generation.

Prostate cancer therapeutics market is becoming more competitive every year with hormonal therapy currently being the largest market drug class for the forecasted period of 2020 to 2027. Data Bridge Market Research’s new report highlights the major growth factors and opportunities in the prostate cancer therapeutics market.

For more analysis on the prostate cancer therapeutics market, request for a briefing with our analysts

Prostate Cancer Therapeutics Market Development

Novartis announced the acquisition of Endocyte in October 2018 which will help the company to strengthen them in the radiopharmaceuticals so they can use better technology to treat cancer. With this acquisition, the company will be adding Lu-PSMA-617 in their portfolio which is a therapy for metastatic castration-resistant prostate cancer. This acquisition will strengthen their market position and will enhance their global reach.

Scope of the Prostate Cancer Therapeutics Market

Prostate cancer therapeutics market on the basis of countries is segmented into U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.

  • All country based analysis of the prostate cancer therapeutics market is further analyzed based on maximum granularity into further segmentation. Based on drug class, prostate cancer therapeutics market is segmented into hormonal therapy, chemotherapy, immunotherapy and targeted therapy. Prostate cancer therapeutics market has also been segmented on the basis of distribution channel into hospital pharmacies, retail pharmacies, online sales and others.
  • Prostate cancer usually occurs in men in their prostate gland which usually develop the fluid that transport & nourished sperms. It is one of the most common types of cancer in men. Some of the common symptom of the prostate cancer includes bone pain, blood in semen, discomfort in pelvic area, and others. This condition usually start occurring when the cells present in the prostate become abnormal. To treat this condition some of the common therapies available are chemotherapy, immunotherapy, hormonal therapy and others.

To know more about the study

Key Pointers Covered in the Prostate Cancer Therapeutics Market Industry Trends and Forecast to 2027

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Regulatory Framework and Changes
  • Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the Report

  • Johnson & Johnson Services, Inc.
  • Astellas Pharma US, Inc.
  • Sanofi
  • Ipsen Pharma
  • AbbVie Inc.
  • Myovant Sciences Ltd.
  • Bayer AG
  • AstraZeneca
  • Tolmar Pharmaceuticals, Inc.
  • Ferring B.V.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc
  • Dendreon Pharmaceuticals LLC.
  • Bristol-Myers Squibb Company
  • Abbott
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd
  • Genentech, Inc
  • Novartis AG

Above are the key players covered in the report, to know about more and exhaustive list of prostate cancer therapeutics companies, contact us

Research Methodology: Prostate Cancer Therapeutics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@